Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NOVAVAX INC | 730,000 | reported | 02 Mar 2013 | tx 8+760,000 |
| Chardan Healthcare Acquisition 2 Corp. | 155,325 | reported | 28 Mar 2022 | tx 1+155,325 |
| ImmunityBio, Inc. | 114,535 | reported | 11 Aug 2020 | tx 7+274,535−65,300 |
| Oncotelic Therapeutics, Inc. | 91,564 | reported | 01 Jun 2016 | tx 9+368,790 |
| Cellectar Biosciences, Inc. | 60,000 | reported | 14 Feb 2025 | tx 10+329,717 |
| Lite Strategy, Inc. | 55,000 | reported | 14 Nov 2025 | tx 11+360,920.5−25,000 |
| Cue Biopharma, Inc. | 24,400 | reported | 02 Jan 2025 | tx 8+144,800 |
| Flexion Therapeutics Inc | 0 | reported | 19 Nov 2021 | tx 22+434,501−268,114 |
| GENELABS TECHNOLOGIES INC /CA | 0 | reported | 07 Jan 2009 | tx 8+452,188−252,188 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Nov 2025 | GRANT_AWARD | Lite Strategy, Inc. | 55,000 | — | deriv |
| 15 Jul 2025 | GRANT_AWARD | Lite Strategy, Inc. | 20,000 | 0.00 USD | deriv |
| 14 Feb 2025 | GRANT_AWARD | Cellectar Biosciences, Inc. | 60,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Cue Biopharma, Inc. | 24,400 | 0.00 USD | deriv |
| 14 Jun 2024 | GRANT_AWARD | Cellectar Biosciences, Inc. | 60,000 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Cue Biopharma, Inc. | 24,400 | 0.00 USD | deriv |
| 29 Sept 2023 | GRANT_AWARD | Lite Strategy, Inc. | 10,000 | 0.00 USD | deriv |
| 28 Jun 2023 | GRANT_AWARD | Cellectar Biosciences, Inc. | 25,000 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Cue Biopharma, Inc. | 10,000 | 0.00 USD | deriv |
| 24 Jun 2022 | GRANT_AWARD | Cellectar Biosciences, Inc. | 7,800 | 0.00 USD | deriv |
| 05 Jul 2022 | GRANT_AWARD | Lite Strategy, Inc. | 87.5 | 0.00 USD | deriv |
| 28 Mar 2022 | GRANT_AWARD | Chardan Healthcare Acquisition 2 Corp. | 155,325 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Cue Biopharma, Inc. | 10,000 | 0.00 USD | deriv |
| 19 Nov 2021 | OTHER | Flexion Therapeutics Inc | 30,680 | 8.50 USD | |
| 19 Nov 2021 | OTHER | Flexion Therapeutics Inc | 168,000 | — | deriv |
| 03 Sept 2021 | PURCHASE | Cellectar Biosciences, Inc. | 19,417 | 1.04 USD | first after silence |
| 01 Jul 2021 | GRANT_AWARD | Lite Strategy, Inc. | 50,000 | 0.00 USD | deriv |
| 30 Jun 2021 | GRANT_AWARD | Cellectar Biosciences, Inc. | 78,000 | 0.00 USD | deriv |
| 01 Jun 2021 | GRANT_AWARD | Flexion Therapeutics Inc | 28,000 | 0.00 USD | |
| 01 Jun 2021 | GRANT_AWARD | Flexion Therapeutics Inc | 168,000 | 0.00 USD | deriv |
| 23 Feb 2021 | SALE | Lite Strategy, Inc. | 25,000 | 4.03 USD | |
| 04 Jan 2021 | GRANT_AWARD | Cue Biopharma, Inc. | 10,000 | 0.00 USD | deriv |
| 11 Aug 2020 | SALE | ImmunityBio, Inc. | 5,300 | 10.77 USD | |
| 11 Aug 2020 | SALE | ImmunityBio, Inc. | 50,000 | 10.22 USD | |
| 11 Aug 2020 | SALE | ImmunityBio, Inc. | 10,000 | 9.98 USD |
5 purchases reported after at least 12 months of silence — most recent on 03 Sept 2021.